TOP1 and cancer: Interestingly, compound 77 exhibited negligible cytotoxicity (CC50 > 100 μM) when tested against human cancer cells; however, it significantly enhanced the cytotoxic activity of the Top1 inhibitor—camptothecin—in cancer cells.